Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06442267 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Comparing Anticoagulation Strategies Using UFH, Argatroban and LMWH for ECMO Support

Study acronym: CASUAL-ECMO
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Jul 30, 2026 to Jan 30, 2027 Completion date: Nov 30, 2026 to Jul 30, 2027 · Start date changed from estimate of Jun 25, 2024 to Jul 30, 2024 · Site details revisedv3 Show 3 more changesShow less
    • Completion date: Nov 30, 2026 to Jul 30, 2027
    • Start date changed from estimate of Jun 25, 2024 to Jul 30, 2024
    • Site details revised
  2. Start date: May 27, 2024 to Jun 25, 2024v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A three-arm randomized controlled non-inferiority pilot study comparing anticoagulation strategies using unfractionated heparin, argatroban and enoxaparin for extracorporeal membrane oxygenation support conducted as an investigator-initiated, prospective, parallel group, open-label, active comparator controlled, single center, phase IV study to evaluate the non-inferiority of enoxaparin or argatroban for anticoagulation during ECMO therapy in comparison to the current standard, unfractionated heparin, as measured by the incidence of thromboembolic events during the duration of ECMO therapy
Trial Details
NCT Number NCT06442267
Lead Sponsor Medical University of Vienna
Conditions Respiratory Insufficiency, Circulatory Failure, Thromboembolism, Bleeding
Enrollment 90 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov